ROSWELL PARK CANCER INSTITUTE — History
CCN 330354 | 3-year financial timeline | COVID resilience: 68/100
🛡️ Public data only — no PHI permitted on this instance.
$772M
Latest Revenue (FY2022)
+8.0%
Revenue CAGR (3yr)
-40.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $662M | $725M | $772M | +6.6% | +8.0% |
| Operating Expenses | $955M | $996M | $1.1B | +8.6% | +6.4% |
| Operating Margin | -44.3% | -37.5% | -40.1% | -7.1% | +0.0% |
| Net Income | $-293M | $-271M | $-310M | -14.1% | +0.0% |
| Licensed Beds | 142 | 142 | 142 | +0.0% | +0.0% |
| Total Patient Days | 40,864 | 44,309 | 43,783 | -1.2% | +3.5% |
| Medicare Day % | 24% | 24% | 25% | +7.9% | +2.5% |
| Medicaid Day % | 1% | 1% | 1% | -34.4% | -11.4% |
COVID Impact & Recovery
Resilience Score: 68/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +16.7% ($662M → $772M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+8.0%
This Hospital
+7.6%
State Avg
Latest Margin
-40.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $828M | -38.0% |
| FY2024 (proj) | $883M | -35.9% |
| FY2025 (proj) | $938M | -33.8% |